PolyPeptide Group AG
SIX:PPGN
PolyPeptide Group AG
SIX:PPGN
Price:
26.55
CHF
1.72%
Market Cap:
CHf879.6m
PolyPeptide Group AG
Other
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
PolyPeptide Group AG
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PolyPeptide Group AG
SIX:PPGN
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bachem Holding AG
SIX:BANB
|
Other
-CHf134k
|
CAGR 3-Years
17%
|
CAGR 5-Years
20%
|
CAGR 10-Years
2%
|
|
|
Siegfried Holding AG
SIX:SFZN
|
Other
-CHf7.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Lonza Group AG
SIX:LONN
|
Other
CHf488m
|
CAGR 3-Years
34%
|
CAGR 5-Years
9%
|
CAGR 10-Years
33%
|
|
|
Tecan Group AG
SIX:TECN
|
Other
-CHf1.9m
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SKAN Group AG
SIX:SKAN
|
Other
-CHf394k
|
CAGR 3-Years
50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
PolyPeptide Group AG
Glance View
PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.
PPGN
Intrinsic Value
23.23
CHF
Overvaluation 13%
